Management of Post-Chemotherapy Residual Masses in Advanced Seminoma
- 1 November 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 168 (5) , 1975-1979
- https://doi.org/10.1016/s0022-5347(05)64275-9
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- The management of residual masses after chemotherapy in metastatic seminomaBJU International, 1999
- Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapyEuropean Journal Of Cancer, 1997
- Surgery for a Post-Chemotherapy Residual Mass in SeminomaJournal of Urology, 1997
- International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.Journal of Clinical Oncology, 1997
- Residual mass following chemotherapy of seminomaAnnals of Oncology, 1997
- Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874British Journal of Cancer, 1995
- Single-agent carboplatinum for advanced seminoma a phase II studyCancer, 1993
- Chemotherapy of Advanced Seminoma: Clinical Significance of Radiological Findings before and after TreatmentBritish Journal of Urology, 1989
- A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.Journal of Clinical Oncology, 1988
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987